Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ningbonxing Medical Electric Co (SHSE:601567) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Jun. 2026) net income data. The Revenue data used here is four times the quarterly (Jun. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Ningbonxing Medical Electric Co ROE % Related Terms
Ningbonxing Medical Electric Co ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Electrical Equipment & Parts subindustry, Ningbonxing Medical Electric Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ningbonxing Medical Electric Co ROE % vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Ningbonxing Medical Electric Co's ROE % distribution charts can be found below:
* The bar in red indicates where Ningbonxing Medical Electric Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Jun. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Ningbonxing Medical Electric Co (SHSE:601567) has a ROE % of 10.77% as of Jun. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Ningbonxing Medical Electric Co and its competitors. This is near median its historical median of 11.84. Over the past decade, Ningbonxing Medical Electric Co's ROE % has ranged from 4.96 to 19.57. According to the industry distribution chart, Ningbonxing Medical Electric Co ranks #1675 out of 3024 companies in the Industrial Products industry, placing it in the top 55.4%.
Is Ningbonxing Medical Electric Co's ROE % too high?
Ningbonxing Medical Electric Co's current ROE % of 10.77% is near median its 10-year median of 11.84. Over the past 10 years, this metric has ranged from a low of 4.96 to a high of 19.57. The Industrial Products industry median ROE % is 6.16. Ningbonxing Medical Electric Co's value of 10.77% is 74.8% above this industry median. Based on the distribution chart, Ningbonxing Medical Electric Co ranks #1675 out of 3024 companies in the Industrial Products industry, which is below the industry midpoint. Overall, Ningbonxing Medical Electric Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ningbonxing Medical Electric Co's ROE % compare to VRT and BE?
According to the Industrial Products industry distribution chart, Ningbonxing Medical Electric Co ranks #1675 out of 3024 companies for ROE %. This places Ningbonxing Medical Electric Co in the lower half of its industry. The industry median ROE % is 6.16. Ningbonxing Medical Electric Co's value of 10.77% is 74.8% above this benchmark. Historically, Ningbonxing Medical Electric Co's own ROE % has ranged from 4.96 to 19.57 over the past decade. While the company's 10-year median is 11.84 vs. the industry median of 6.16, Ningbonxing Medical Electric Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for an Industrial Products company?
The median ROE % among Industrial Products companies is 6.16, based on 3,024 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ningbonxing Medical Electric Co's current ROE % of 10.77% is 74.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Ningbonxing Medical Electric Co and its competitors. For the Industrial Products industry, the median ROE % is 6.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ningbonxing Medical Electric Co's current ROE % is 10.77%, which is near median its own 10-year median of 11.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningbonxing Medical Electric Co stock overvalued right now?
Based on GuruFocus' analysis, Ningbonxing Medical Electric Co (SHSE:601567) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥27.18, compared to a current price of ¥14.21 — trading 47.7% below its estimated fair value. The current ROE % is 10.77%, which is near median its 10-year median of 11.84 and 74.8% above the Industrial Products industry median of 6.16. Ningbonxing Medical Electric Co's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Ningbonxing Medical Electric Co (SHSE:601567), the current ROE % is 10.77% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ningbonxing Medical Electric Co (SHSE:601567) Overvalued in 2026?
Based on GuruFocus' analysis, Ningbonxing Medical Electric Co stock appears to be undervalued.
The current stock price of ¥14.21 is trading 47.7% below its estimated GF Value™ of ¥27.18.
GuruFocus considers Ningbonxing Medical Electric Co to be Significantly Undervalued.
Key valuation signals for SHSE:601567:
ROE %: 10.77% (near median its 10-year median of 11.84)
GF Value™: ¥27.18 vs. price of ¥14.21 (47.7% below fair value)
Industry Position: 74.8% above the Industrial Products median (#1675 of 3024)
No single metric tells the full story. See the SHSE:601567 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ningbo Sanxing Medical Electric Co Ltd operates in the electricity measurement industry. The product portfolio of the group includes the Meter box, Smart substation, Switchgear, Power distribution automation devices, and others. The company also operates in the Medical Service segment, which is mainly engaged in the construction, operation, investment, and acquisition of hospitals, as well as the finance leasing of hospitals, among others. It generates the majority of its revenue from the Intelligent power distribution segment.
70GF Score
Get the complete analysis for SHSE:601567
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:601567 has been successfully added to your 
